FDA Drug Application (015103) for REGROTON by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number015103
Product Number001
FormTABLET;ORAL
Dosage50MG;0.25MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameREGROTON
Active IngredientCHLORTHALIDONE; RESERPINE

Active IngredientCount
List of drugs with Active Ingredient CHLORTHALIDONE14
List of drugs with Active Ingredient RESERPINE52


Back to FDA Applications sponsored by SANOFI AVENTIS US